230 related articles for article (PubMed ID: 36787937)
21. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
22. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC; Contreras G; Dwyer JP; Freedman BI; Ix JH; Kirchner K; Papademetriou V; Pisoni R; Rocco MV; Whelton PK; Greene T
J Am Soc Nephrol; 2019 Aug; 30(8):1523-1533. PubMed ID: 31324734
[TBL] [Abstract][Full Text] [Related]
23. The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial.
Yang R; Wang Y; Tong A; Yu J; Zhao D; Cai J
Eur J Intern Med; 2023 Jul; 113():75-82. PubMed ID: 37142449
[TBL] [Abstract][Full Text] [Related]
24. Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes.
Ku E; McCulloch CE; Copeland TP; Inker LA; Tighiouart H; Sarnak MJ
Am J Kidney Dis; 2023 Oct; 82(4):454-463. PubMed ID: 37269972
[TBL] [Abstract][Full Text] [Related]
25. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
26. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
[TBL] [Abstract][Full Text] [Related]
27. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
[TBL] [Abstract][Full Text] [Related]
28. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Hypertension: Which Goal for Which Patient?
Jarraya F
Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
[TBL] [Abstract][Full Text] [Related]
30. Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.
Nadkarni GN; Chauhan K; Rao V; Ix JH; Shlipak MG; Parikh CR; Coca SG
Am J Kidney Dis; 2019 Jan; 73(1):31-38. PubMed ID: 30291011
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering.
Wang S; Khera R; Das SR; Vigen R; Wang T; Luo X; Lu R; Zhan X; Xiao G; Vongpatanasin W; Xie Y
Am J Cardiol; 2018 Jul; 122(2):248-254. PubMed ID: 29880288
[TBL] [Abstract][Full Text] [Related]
32. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
[TBL] [Abstract][Full Text] [Related]
33. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
[TBL] [Abstract][Full Text] [Related]
34. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
[TBL] [Abstract][Full Text] [Related]
35. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
36. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
37. J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial.
Attar A; Nouri F; Borazjani R; Sayadi M
PLoS One; 2020; 15(10):e0240102. PubMed ID: 33002071
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.
Mezue K; Goyal A; Pressman GS; Matthew R; Horrow JC; Rangaswami J
J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1247-1252. PubMed ID: 29984884
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J; Gren LH; Zamanian S; Cushman WC;
J Hypertens; 2020 Aug; 38(8):1567-1577. PubMed ID: 32371767
[TBL] [Abstract][Full Text] [Related]
40. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
